跳至主要内容
临床试验/ITMCTR2000003008
ITMCTR2000003008招募中1 期

Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19)

The First Affiliated Hospital of He'nan University of Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 90(—)
性别
All

入选标准

  • 1. General/severe/critical patients who meet the diagnostic criteria of new coronavirus pneumonia;
  • 2. Patients whose viral nucleic acid has turned negative after treatment;
  • 3. Patients who are characterized by respiratory symptoms such as cough, shortness of breath, chest tightness or corresponding chest imaging features;
  • 4. Patients who meet TCM syndrome;
  • 5. Patients who voluntarily participate in the study and sign informed consent.

排除标准

  • 1. Patients with cognitive disorder or known mental illness;
  • 2. Pregnant or lactating women;
  • 3. Patients with active tuberculosis, pulmonary abscess or chronic respiratory failure;
  • 4. Patients with tumor;
  • 5. Patients with severe liver or kidney diseases;
  • 6. Patients with severe cardiovascular or cerebrovascular diseases;
  • 7. Patients who are participating in clinical trials of other drugs, or known to be allergic to therapeutic drugs.

研究者

发起方
The First Affiliated Hospital of He'nan University of Chinese Medicine

相似试验